NCT02162732 2025-11-03Molecular-Guided Therapy for Childhood CancerMilton S. Hershey Medical CenterPhase NA Completed186 enrolled 12 charts
NCT01967823 2021-03-24T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing CancerNational Institutes of Health Clinical Center (CC)Phase 2 Completed11 enrolled 12 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts